Predicting and preparing for the unfolding evolution of SARS-CoV-2
- Funded by National Health and Medical Research Council (NHMRC)
- Total publications:1 publications
Grant number: 2012883
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$740,678.51Funder
National Health and Medical Research Council (NHMRC)Principal Investigator
Prof. Alexander KhromykhResearch Location
AustraliaLead Research Institution
University of QueenslandResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen genomics, mutations and adaptations
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
One year on from the emergence of the COVID-19 pandemic, variants of SARS-CoV-2 have evolved to be more transmissible, pathogenic and less susceptible to immune responses from infection or vaccination. We propose utilising the deep mutational scanning method to examine the molecular pathogenesis and vaccine escape of SARS-CoV-2 at a single amino acid residue resolution and towards developing a universal vaccine candidate to neutralise all potential future SARS-CoV-2 variants.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC